Stock listing
897966 Stock Price, News, Filings & Events — Sysmex Corporation
Selected listing: 897966 · LSX · EUR · DE
This page tracks Sysmex Corporation's 897966:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 897966:LSX. 897966:LSX is the stock-level entry point for investors researching Sysmex Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- 897966:LSX
- Asset type
- Stock
- Market cap
- $7.18B
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- LSX
- Currency
- EUR
Sysmex Corporation 897966:LSX stock context
This page tracks Sysmex Corporation's 897966:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 897966:LSX. 897966:LSX is the stock-level entry point for investors researching Sysmex Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Sysmex Corporation
Announcement Regarding Revision of Financial Forecast for FY26 1H and FY26 full year
August 7, 2026
Notice Regarding the Status and Completion of Acquisition of Treasury Stock and Cancellation of Treasury Stock
July 22, 2026
Sysmex : HIGH DIAGNOSTIC PERFORMANCE OF THE RANDOM-ACCESS HISCL pTAU-217, Aβ42 AND Aβ40 PLASMA ASSAYS IN DETECTING AMYLOID PATHOLOGY ACROSS CLINICAL STAGES
July 16, 2026
Notice Concerning the Status of Acquisition of Treasury Stock
July 2, 2026
Sysmex : Genetic Testing Using Sysmex’s Assay Kit Receives Insurance Coverage as the First of Its Kind in Japan for Assessing the Risk of Adverse Reactions to Anti-Amyloid β Antibody Drugs
July 1, 2026
Research Sysmex Corporation
Sysmex Corporation investor report
Review AI stock analysis and investor report context for 897966:LSX.
Sysmex Corporation company profile
View the public company page for Sysmex Corporation on 6ix.
Sysmex Corporation news
Read company news and market updates connected to Sysmex Corporation.
Sysmex Corporation investor events
Find investor webinars, events, and replay context for Sysmex Corporation.
Alternate listings
6869:TSE
JP · JPY
Alternate listing for Sysmex Corporation; the primary context on this page is 897966:LSX.
SSMXY:OTC
US · USD
Alternate listing for Sysmex Corporation; the primary context on this page is 897966:LSX.
0YX:GETTEX
DE · EUR
Alternate listing for Sysmex Corporation; the primary context on this page is 897966:LSX.
0YX:TRADEGATE
DE · EUR
Alternate listing for Sysmex Corporation; the primary context on this page is 897966:LSX.
SSMXF:OTC
US · USD
Alternate listing for Sysmex Corporation; the primary context on this page is 897966:LSX.
0YX:FWB
DE · EUR
Alternate listing for Sysmex Corporation; the primary context on this page is 897966:LSX.
897966:LS
DE · EUR
Alternate listing for Sysmex Corporation; the primary context on this page is 897966:LSX.
6869N:BMV
MX · MXN
Alternate listing for Sysmex Corporation; the primary context on this page is 897966:LSX.
0YX:DUS
DE · EUR
Alternate listing for Sysmex Corporation; the primary context on this page is 897966:LSX.
0YX:HAN
DE · EUR
Alternate listing for Sysmex Corporation; the primary context on this page is 897966:LSX.
0YX:MUN
DE · EUR
Alternate listing for Sysmex Corporation; the primary context on this page is 897966:LSX.
0YX:SWB
DE · EUR
Alternate listing for Sysmex Corporation; the primary context on this page is 897966:LSX.